Clover Health Investments Corp (CLOV)
$0.89
0.04 (4.70%)
CLOV Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
6.80M
Day's Range
$0.89 - $0.93
52-Week Range
$0.61 - $1.63
Dividend & Yield
N/A (N/A)
CLOV Stock Predictions, Articles, and Clover Health Investments Corp News
As Clover Health Stock Gets Diluted, Stockholders Are Giving Up
CLOV stock continues to punish long-suffering shareholders as it losses value. The latest public offering at the low-ball price of $5.75 is another nail in the coffin.
Clover Health Is Now a Penny Stock, Denoting Its Serious Decline
CLOV stock is saddled with issues that include a declining share price and operational issues that are only getting more troublesome.
MEME ETF: The Top 10 Holdings of the New Roundhill Fund for Meme Stock Investors
The new Roundhill MEME ETF (MEME) is live and with it comes an opportunity to invest in a wide variety of meme stocks it holds.
With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock
Likely to languish at or below $5 per share for a while, skip out for now with CLOV stock.
If November Is Any Indication, Clover Health Is on Life Support
November was brutal for shareholders of Clover Health. CLOV stock lost close to 40% of its value. Trading under $5, it’s tough to recommend.
The Engine Boosting Clover Health Stock is a CTO Working to Disrupt Medicare
The Clover Assistant is meant to align incentives between health care providers and managed care companies, which could cut costs and create profits. That's what CLOV stock investors should focus on.
The Clover Health Dilemma: Is it a Good Buy or Goodbye?
Last rites for Clover Health Investments seem premature, but CLOV stock is being challenged off and on the price chart.
Clover Health Is Expanding, But Its Path to Profitability Is Unclear
Clover provides a relevant solution and is expanding, but its cash flow makes CLOV stock an unattractive pick at this point.
CLOV Stock: The Chamath Palihapitiya Tweet Giving Clover Health a Lift Today
Clover Health Investments (CLOV) stock is getting a boost on Friday thanks to a couple of Tweets from Chamath Palihapitiya.
CLOV Stock Alert: There’s a $300M Reason Clover Health Is Stumbling Today
Meme stock favorite Clover Health is under pressure today after announcing a new secondary stock offering that has upset investors.
Revenue Growth Makes Clover Health Stock a Strong Buy
A combination of triple-digit growth, expanding provider networks and a low share price make CLOV stock hard to resist.
Could Clover Be Starting to Make a Comeback?
Clover Health's poor insurance underwriting performance dragged down CLOV stock. However, the company may be making progress.
What Investors Should Remember About Clover Health
There is no question Clover Health remains a risky proposition. However, there is one thing about CLOV stock that could make a difference.
Clover Health Has Long Term Potential with Short Term Volatility
CLOV stock has a legitimate bullish thesis to play out well over time. Meanwhile, investors have to stomach the short term shenanigans.
Clover Health Stock Has an Outside Chance of Suprising in Its Upcoing Earnings
If you strongly believe the company's heavy losses are transitory? By all means, roll the dice with CLOV stock. But if you think it'll still have cost control issues? Or, that other risks will continue to weigh down on it? Holding off for now may be the way to go.
The Outlook of Clover Stock Is Deteriorating
CLOV stock has been a disappointment for many reasons. Given the company's poor fundamentals, it's not worth investing in.
Clover Health Stock Is Still Risky, But Speculators Could Consider It
While conservative investors will want to stay away from risky CLOV stock, speculators can play its recent news item.
